News Roundup: ASH Annual Meeting, Drug Topics Year in Review
Here’s a roundup of the latest news from Drug Topics®.
Year in Review: 2021 Top News from Drug Topics®
https://www.drugtopics.com/view/year-in-review-2021-top-news-from-drug-topics-
Best of the Best: Sidrah Alam on Her Road to Pharmacy School
https://www.drugtopics.com/view/best-of-the-best-sidrah-alam-on-her-road-to-pharmacy-school
New Drug Review: Atogepant FDA-Approved for Migraine Treatment
https://www.drugtopics.com/view/new-drug-review-atogepant-fda-approved-for-migraine-treatment
Probiotics Can Help Treat Candidiasis, Study Shows
https://www.drugtopics.com/view/probiotics-can-help-treat-candidiasis-study-shows
New Drug Approvals in Pediatrics
https://www.drugtopics.com/view/new-drug-approvals-in-pediatrics
Slow Going: Progress to Resolve Drug Supply Chain Issues Is Minimal
https://www.drugtopics.com/view/slow-going-progress-to-resolve-drug-supply-chain-issues-is-minimal
Profits Soar, But Pay Stays the Same: Chain Pharmacists Are Ready to Speak Up
COVID-19 Infection, Vaccination Outcomes in Explored at ASH Annual Meeting
FDA’s Recent Exemptions: What Do They Mean as We Finalize DSCSA Implementation?
October 31st 2024Kala Shankle, Vice President of Regulatory Affairs with the Healthcare Distribution Alliance, and Ilisa Bernstein, President of Bernstein Rx Solutions, LLC, discussed recent developments regarding the Drug Supply Chain Security Act.
